ClinConnect ClinConnect Logo
Search / Trial NCT06961825

Brief Title: The Role of Nutrition in the Rehabilitation of Patients With Eating Disorders After a Vascular Stroke.

Launched by UNIVERSITY OF IOANNINA · Apr 29, 2025

Trial Information

Current as of July 25, 2025

Not yet recruiting

Keywords

Protein Supplementation Nutritional Intervention Albumin Levels Stroke Stroke Rehabilitation Eating Disorders Malnutrition Nutritional Assessment Sarcopenia Osteopenia

ClinConnect Summary

This clinical trial is exploring how nutrition, specifically the use of protein supplements, can help patients who have had a stroke and are experiencing low protein levels in their blood, a condition known as hypoalbuminemia. The goal is to see if providing either a single or double dose of protein supplements can improve recovery in these patients, especially in terms of muscle strength, bone health, and overall physical functioning. Participants will be divided into three groups: one will not receive any protein supplements, while the other two groups will receive either a single or double dose for at least six weeks. Throughout the study, researchers will closely monitor various health markers and physical abilities to understand the impact of nutrition on recovery.

To participate in this trial, individuals must be between the ages of 18 and 85, have had a stroke in the past 4 to 6 weeks, and have low levels of protein in their blood. They should also be in need of nutritional support for recovery. However, those with severe infections, serious heart or lung issues, certain other health conditions, or severe mental health challenges that prevent them from understanding or consenting to the study will not be eligible. This research is important because it aims to improve how we support stroke recovery through better nutritional strategies, potentially leading to new guidelines for treating patients with low protein levels.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age range: Adults aged 18 to 85 years
  • Diagnosis: Patients diagnosed with a stroke (cerebrovascular accident) within the last 4 to 6 weeks
  • Serum albumin levels: Patients with low serum albumin levels (\< 3.5 g / dL)
  • Nutritional intervention requirement: Patients who require nutritional intervention to support rehabilitation and nutrition
  • Informed consent: Patients who have completed the consent form for participation in the study and acceptance of the intervention
  • Exclusion Criteria:
  • Severe infections or serious cardiopulmonary conditions: Patients with severe infections or serious cardiopulmonary conditions requiring immediate medical intervention, which may affect nutrition and rehabilitation
  • Comorbidities: Patients with comorbid conditions such as renal or liver disease
  • History of stroke or neurological conditions: Patients with a history of stroke or other neurological conditions who do not meet the criteria for rehabilitation
  • Severe mental or psychological conditions: Patients with severe mental or psychological conditions who are unable to understand or consent to participation in the study

About University Of Ioannina

The University of Ioannina, located in Greece, is a leading academic institution renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative studies aimed at improving healthcare outcomes. With a focus on collaborative research, the University of Ioannina engages in multidisciplinary partnerships and adheres to rigorous ethical standards, ensuring the integrity and reliability of its clinical trials. Through its dedication to scientific excellence, the university aims to contribute significantly to the body of medical knowledge and the development of effective therapeutic interventions.

Locations

Ioannina, , Greece

Patients applied

0 patients applied

Trial Officials

Avraam Ploumis

Principal Investigator

University Hospital, Ioannina

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported